Clinical Trial Update: Nitazoxanide Therapy for Patients With COVID-19 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nitazoxanide therapy for patients with COVID-19 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Pneumonia Viral

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Covid19, Corona Virus Infection | Phase 2 | Status: COMPLETED